Advanced Biomed (NASDAQ:ADVB) Announces Earnings Results

Advanced Biomed (NASDAQ:ADVB) announced its quarterly earnings data on Friday. The company reported ($0.38) earnings per share (EPS) for the quarter, Zacks reports.

Advanced Biomed Price Performance

ADVB traded down $0.03 during mid-day trading on Friday, hitting $4.40. The stock had a trading volume of 13,558 shares, compared to its average volume of 391,197. The business’s fifty day simple moving average is $5.20. The firm has a market cap of $5.98 million, a price-to-earnings ratio of 1.16 and a beta of 0.56. Advanced Biomed has a 1-year low of $3.61 and a 1-year high of $25.60.

Analyst Ratings Changes

Separately, Weiss Ratings initiated coverage on shares of Advanced Biomed in a research note on Monday, January 26th. They issued a “sell (e+)” rating on the stock. One analyst has rated the stock with a Sell rating, Based on data from MarketBeat.com, the company has a consensus rating of “Sell”.

Advanced Biomed Company Profile

Our Mission We are committed to the application research of integrating semiconductor technology and biotechnology. Through the enrichment, capture, and identification of circulating tumor cells and related tumor marker cells in the field of liquid biopsy, we aim to provide cancer patients with rapid and affordable assay products and services. These services include early screening and detection, diagnosis and staging, treatment selection, and patient outcome interventions for cancer. We are a holding company incorporated in the State of Nevada.